• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用对接和 3D-QSAR 研究 d-稠合苯并氮杂卓酮作为 VEGF-R2 激酶抑制剂的分子建模研究。

Molecular modelling studies on d-annulated benzazepinones as VEGF-R2 kinase inhibitors using docking and 3D-QSAR.

机构信息

Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, China.

出版信息

J Enzyme Inhib Med Chem. 2011 Jun;26(3):367-77. doi: 10.3109/14756366.2010.513331. Epub 2010 Sep 17.

DOI:10.3109/14756366.2010.513331
PMID:20846090
Abstract

Chemotypes comprising the d-annulated 1,3-dihydro-2H-1-benzazepin-2-one scaffold derived from the paullone structure were found to be potent vascular endothelial growth factor receptor 2 (VEGF-R2) kinase inhibitors. Three-dimensional quantitative structure-activity relationship (3D-QSAR) and docking studies were performed on a series of d-annulated benzazepinones with VEGF-R2 kinase inhibition activities. The comparative molecular field analysis and comparative molecular similarity indices analysis models using 32 molecules in the training set gave r(2)(cv) values of 0.811 and 0.769, r(2) values of 0.962 and 0.953, respectively. 3D contour maps generated from the two models revealed that the electron-withdrawing groups at R(1) and the bulky, electron-withdrawing as well as hydrogen bond donor groups at R(2) position are favourable; the bulky, hydrogen bond acceptor substituent at R(3) and the minor groups at R(4) position may benefit the potency. We have designed a series of novel VEGF-R2 inhibitors by utilizing the SAR results revealed in the present study, which were predicted with excellent potencies in the developed models. The results may aid in designing of potential VEGF-R2 inhibitors with better activities.

摘要

从保尔酮结构衍生而来的 d-稠合 1,3-二氢-2H-1-苯并氮卓-2-酮骨架的化学型被发现是强效的血管内皮生长因子受体 2(VEGF-R2)激酶抑制剂。对一系列具有 VEGF-R2 激酶抑制活性的 d-稠合苯并氮卓酮进行了三维定量构效关系(3D-QSAR)和对接研究。使用训练集中的 32 个分子的比较分子场分析和比较分子相似性指数分析模型分别给出了 0.811 和 0.769 的 r(2)(cv) 值,0.962 和 0.953 的 r(2) 值。两个模型生成的 3D 等高线图表明,R(1)处的吸电子基团和 R(2)处的大体积、吸电子和氢键供体基团是有利的;R(3)处的大体积、氢键受体取代基和 R(4)处的小基团可能有利于活性。我们利用本研究中揭示的 SAR 结果设计了一系列新型 VEGF-R2 抑制剂,这些抑制剂在开发的模型中具有优异的预测活性。这些结果可能有助于设计具有更好活性的潜在 VEGF-R2 抑制剂。

相似文献

1
Molecular modelling studies on d-annulated benzazepinones as VEGF-R2 kinase inhibitors using docking and 3D-QSAR.利用对接和 3D-QSAR 研究 d-稠合苯并氮杂卓酮作为 VEGF-R2 激酶抑制剂的分子建模研究。
J Enzyme Inhib Med Chem. 2011 Jun;26(3):367-77. doi: 10.3109/14756366.2010.513331. Epub 2010 Sep 17.
2
Identification of 2-anilino-9-methoxy-5,7-dihydro-6H-pyrimido[5,4-d][1]benzazepin-6-ones as dual PLK1/VEGF-R2 kinase inhibitor chemotypes by structure-based lead generation.基于结构的先导物生成技术鉴定 2-苯胺基-9-甲氧基-5,7-二氢-6H-嘧啶并[5,4-d][1]苯并氮杂卓-6-酮类化合物为双重 PLK1/VEGF-R2 激酶抑制剂类化合物。
J Med Chem. 2010 Mar 25;53(6):2433-42. doi: 10.1021/jm901388c.
3
Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking.使用定量构效关系(QSAR)和对接技术对血管内皮生长因子受体酪氨酸激酶抑制剂进行分子模拟研究。
J Mol Graph Model. 2009 Jan;27(5):642-54. doi: 10.1016/j.jmgm.2008.10.006. Epub 2008 Nov 5.
4
Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.基于 1,4-二氢茚并[1,2-c]吡唑类 VEGFR-2 激酶抑制剂的三维定量构效关系建模和分子对接研究。
J Mol Graph Model. 2010 Aug 24;29(1):54-71. doi: 10.1016/j.jmgm.2010.04.004. Epub 2010 Apr 24.
5
Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.基于 3D-QSAR 和对接方法的咪唑并[4,5-b]吡啶衍生物作为 Aurora A 激酶抑制剂的分子模拟研究。
Eur J Med Chem. 2011 Jan;46(1):77-94. doi: 10.1016/j.ejmech.2010.10.017. Epub 2010 Oct 26.
6
Pharmacophore and docking-based combined in-silico study of KDR inhibitors.基于药效团和对接的KDR抑制剂计算机辅助联合研究
J Mol Graph Model. 2009 Aug;28(1):54-61. doi: 10.1016/j.jmgm.2009.04.006. Epub 2009 Apr 19.
7
3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors.基于 3D-QSAR 和对接研究的吡唑并[4,3-h]喹唑啉-3-甲酰胺类作为细胞周期蛋白依赖性激酶 2(CDK2)抑制剂。
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6764-72. doi: 10.1016/j.bmcl.2010.08.131. Epub 2010 Sep 24.
8
Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.基于受体的检查点Wee1激酶抑制剂的3D-QSAR研究。
Eur J Med Chem. 2009 Apr;44(4):1383-95. doi: 10.1016/j.ejmech.2008.09.027. Epub 2008 Sep 30.
9
Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.使用定量构效关系(QSAR)和对接技术对作为p38激酶抑制剂的苯氧基嘧啶基咪唑进行分子模拟研究。
Eur J Med Chem. 2008 Apr;43(4):830-8. doi: 10.1016/j.ejmech.2007.06.009. Epub 2007 Jul 6.
10
3D QSAR studies on a series of potent and high selective inhibitors for three kinases of RTK family.对一系列针对受体酪氨酸激酶(RTK)家族三种激酶的强效且高选择性抑制剂的三维定量构效关系(3D QSAR)研究。
J Mol Graph Model. 2007 Jul;26(1):236-45. doi: 10.1016/j.jmgm.2006.12.001. Epub 2006 Dec 8.

引用本文的文献

1
Vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors: development and validation of predictive 3-D QSAR models through extensive ligand- and structure-based approaches.血管内皮生长因子受体-2(VEGFR-2)抑制剂:通过广泛的基于配体和结构的方法开发和验证预测性三维定量构效关系模型
J Comput Aided Mol Des. 2015 Aug;29(8):757-76. doi: 10.1007/s10822-015-9859-y. Epub 2015 Jul 21.
2
The discovery of potentially selective human neuronal nitric oxide synthase (nNOS) Inhibitors: a combination of pharmacophore modelling, CoMFA, virtual screening and molecular docking studies.潜在选择性人神经元型一氧化氮合酶(nNOS)抑制剂的发现:药效团建模、比较分子力场分析(CoMFA)、虚拟筛选和分子对接研究的结合
Int J Mol Sci. 2014 May 14;15(5):8553-69. doi: 10.3390/ijms15058553.